Literature DB >> 20546242

Isolation of therapeutically functional mouse bone marrow mesenchymal stem cells within 3 h by an effective single-step plastic-adherent method.

F S-H Hsiao1, C-C Cheng, S-Y Peng, H-Y Huang, W-S Lian, M-L Jan, Y-T Fang, E C-H Cheng, K-H Lee, W T-K Cheng, S-P Lin, S-C Wu.   

Abstract

OBJECTIVES: Isolation of mouse mesenchymal stem cells (mMSCs), by the approach of plastic adherence, has been difficult due to persistent contamination by haematopoietic cells (HCs); we have observed that this contamination was due to engagement between HCs and mMSCs. The HCs can be lifted together with the mMSCs despite their insensitivity to trypsin digestion. Herein, we provide a single-step procedure to rapidly segregate mMSCs from HC contaminants using transient lower-density plastic adherence (tLDA).
MATERIALS AND METHODS: The tLDA was performed by replating bone marrow adherent cells at lower density (1.25 x 10(4) cells/cm(2)) than usual, allowing for transient adherence of no more than 3 h, followed by trypsin digestion. tLDA-isolated cells were evaluated by immunophenotyping, multi-differentiation potentials, immunosuppressive properties, and therapeutic potential as demonstrated by symptoms of osteoporosis.
RESULTS: The single-step tLDA method can effectively eliminate the persistent HC contaminants; tLDA-isolated cells were phenotypically equivalent to those reported as mMSCs. The isolated cells possessed classic tri-lineage differentiation potential into osteogenic, adipogenic and chondrogenic lineages and had immunosuppressive properties. After intravenous transplantation, they migrated into the allogeneic bone marrow and rescued hosts from osteoporosis symptoms, demonstrating their therapeutic potential.
CONCLUSIONS: We have developed a simple and economical method that effectively isolates HC-free, therapeutically functional mMSCs from bone marrow cell adherent cultures. These cells are suitable for various mechanistic and therapeutic studies in the mouse model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546242      PMCID: PMC6496704          DOI: 10.1111/j.1365-2184.2010.00674.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  55 in total

Review 1.  Mesenchymal stem cells: paradoxes of passaging.

Authors:  Elisabeth H Javazon; Kirstin J Beggs; Alan W Flake
Journal:  Exp Hematol       Date:  2004-05       Impact factor: 3.084

Review 2.  Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.

Authors:  Darwin J Prockop; Scott D Olson
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

3.  Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

Authors:  Olle Ringdén; Mehmet Uzunel; Ida Rasmusson; Mats Remberger; Berit Sundberg; Helena Lönnies; Hanns-Ulrich Marschall; Aldona Dlugosz; Attila Szakos; Zuzana Hassan; Brigitta Omazic; Johan Aschan; Lisbeth Barkholt; Katarina Le Blanc
Journal:  Transplantation       Date:  2006-05-27       Impact factor: 4.939

4.  'Green mice' as a source of ubiquitous green cells.

Authors:  M Okabe; M Ikawa; K Kominami; T Nakanishi; Y Nishimune
Journal:  FEBS Lett       Date:  1997-05-05       Impact factor: 4.124

5.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

Authors:  E M Horwitz; D J Prockop; L A Fitzpatrick; W W Koo; P L Gordon; M Neel; M Sussman; P Orchard; J C Marx; R E Pyeritz; M K Brenner
Journal:  Nat Med       Date:  1999-03       Impact factor: 53.440

6.  Adhesion molecules involved in the interactions between early T cells and mesenchymal bone marrow stromal cells.

Authors:  M Barda-Saad; L A Rozenszajn; H Ashush; Y Shav-Tal; A Ben Nun; D Zipori
Journal:  Exp Hematol       Date:  1999-05       Impact factor: 3.084

Review 7.  Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development?

Authors:  E I Deryugina; C E Müller-Sieburg
Journal:  Crit Rev Immunol       Date:  1993       Impact factor: 2.214

8.  Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection.

Authors:  Melody Baddoo; Katy Hill; Robin Wilkinson; Dina Gaupp; Catherine Hughes; Gene C Kopen; Donald G Phinney
Journal:  J Cell Biochem       Date:  2003-08-15       Impact factor: 4.429

9.  Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-Sca-1 monoclonal antibody and wheat germ agglutinin.

Authors:  P Van Vlasselaer; N Falla; H Snoeck; E Mathieu
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

10.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

Authors:  Mauro Krampera; Sarah Glennie; Julian Dyson; Diane Scott; Ruthline Laylor; Elizabeth Simpson; Francesco Dazzi
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

View more
  16 in total

Review 1.  Stem cell therapy for osteoporosis.

Authors:  Ben Antebi; Gadi Pelled; Dan Gazit
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 2.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

3.  Isolation, characterization, and differentiation of stem cells for cartilage regeneration.

Authors:  Olivia S Beane; Eric M Darling
Journal:  Ann Biomed Eng       Date:  2012-08-21       Impact factor: 3.934

4.  Basal expression of pluripotency-associated genes can contribute to stemness property and differentiation potential.

Authors:  Nidheesh Dadheech; Abhay Srivastava; Muskaan Belani; Sharad Gupta; Rajarshi Pal; Ramesh R Bhonde; Anand S Srivastava; Sarita Gupta
Journal:  Stem Cells Dev       Date:  2013-03-08       Impact factor: 3.272

5.  Resistance of bone marrow stroma to genotoxic preconditioning is determined by p53.

Authors:  Natalia Fedtsova; Elena A Komarova; Kellee F Greene; Liliya R Novototskaya; Ivan Molodtsov; Craig M Brackett; Evguenia Strom; Anatoli S Gleiberman; Alexander N Shakhov; Andrei V Gudkov
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

6.  Isolation and characterization of novel murine epiphysis derived mesenchymal stem cells.

Authors:  Chun-Chun Cheng; Wei-Shiung Lian; Felix Shih-Hsiang Hsiao; I-Hsuan Liu; Shau-Ping Lin; Yen-Hua Lee; Chia-Chun Chang; Guan-Yu Xiao; Hsin-Yi Huang; Ching-Feng Cheng; Winston Teng-Kuei Cheng; Shinn-Chih Wu
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

7.  Osteoblast-secreted factors promote proliferation and osteogenic differentiation of bone marrow stromal cells via VEGF/heme-oxygenase-1 pathway.

Authors:  Lian-Fang Zhang; Jin Qi; GuiLai Zuo; Peng Jia; Xing Shen; Jin Shao; Hui Kang; HuiLin Yang; LianFu Deng
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

8.  Amniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy.

Authors:  Guan-Yu Xiao; I-Hsuan Liu; Chun-Chun Cheng; Chia-Chun Chang; Yen-Hua Lee; Winston Teng-Kuei Cheng; Shinn-Chih Wu
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

9.  Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.

Authors:  Guan-Yu Xiao; Chun-Chun Cheng; Yih-Shien Chiang; Winston Teng-Kuei Cheng; I-Hsuan Liu; Shinn-Chih Wu
Journal:  Sci Rep       Date:  2016-03-16       Impact factor: 4.379

10.  Umbilical cord extracts improve osteoporotic abnormalities of bone marrow-derived mesenchymal stem cells and promote their therapeutic effects on ovariectomised rats.

Authors:  Akira Saito; Kanna Nagaishi; Kousuke Iba; Yuka Mizue; Takako Chikenji; Miho Otani; Masako Nakano; Kazusa Oyama; Toshihiko Yamashita; Mineko Fujimiya
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.